Hand of the Market
Screener
Sectors
Compare
Insider buys
Funds
 Screener

IDXX IDEXX LABORATORIES INC /DE

Compare with sector and industry Screen the industry

Health Care · Pharmaceuticals & Biotechnology · data as of 2026-10-22 · latest quarter 2026-06-30, filed 2026-08-04

Market cap
$44.7B
P/E (trailing)
39.2×
P/E vs. sector
1.5×
FCF yield
2.8%
Avg daily $ volume
$281.22M
Days to next report
11
Quality checklist

6 of 6 checks passed · quarter ending 2026-06-30

  • ROIC at least 10%48.9%
  • Operating margin up over 3 years+2.2 pp
  • Free cash flow at least 80% of net income110.1%
  • Share count up at most 5% in 3 years-5.0%
  • Net debt at most 3× EBITDA0.5×
  • Revenue grew over 3 years9.0%
Insider buying, last 90 days

No discretionary insider buying in the last 90 days.

Tracked funds, latest reports
Active managers
−$90.79M −0.2 pp of the company
2 buying · 3 selling · 4 holding
Mutual funds & ETFs
−$20.81M −0.0 pp of the company
3 buying · 1 selling · 5 holding

Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.

Size & liquidity
IDXXSector12 quartersMarket cap$44.7B$9.67BEnterprise value$45.47B$10.41BAvg daily $ volume$281.22M$132.68MDaily turnover0.6%1.3%
Growth
IDXXSector12 quartersRevenue CAGR 3y9.0%9.5%7.5% → 9.0%Revenue CAGR 5y8.4%8.9%Revenue growth YoY9.7%8.7%8.8% → 9.7%Revenue acceleration−4.6 pp+0.0 pp−0.9 pp → −4.6 ppFCF growth YoY59.9%5.9%51.7% → 59.9%FCF conversion110.1%130.8%82.6% → 110.1%Forward growth (HoM est.)9.3%9.8%
Valuation
IDXXSector12 quartersP/E (trailing)39.2×27.6×P/E (forward, HoM est.)35.9×25.2×P/E vs. sector1.5×1.0×PEG (HoM est.)3.843.12EV/EBITDA28.2×17.5×EV/Sales10.0×3.3×FCF yield2.8%3.6%Dividend yield0.0%0.0%Shareholder yield2.6%1.2%
Quality
IDXXSector12 quartersQuality checks passed63ROIC48.9%9.2%43.2% → 48.9%Gross profitability82.6%32.6%69.6% → 82.6%Gross margin62.5%60.1%59.9% → 62.5%Gross margin Δ 3y+2.5 pp−0.1 pp+1.6 pp → +2.5 ppOperating margin32.0%10.6%30.1% → 32.0%Operating margin Δ 3y+2.2 pp+0.9 pp+0.3 pp → +2.2 ppDebt/equity0.6×0.7×0.8× → 0.6×Net debt/EBITDA0.5×2.0×0.6× → 0.5×Interest coverage38.6×4.9×23.5× → 38.6×Share count Δ 3y-5.0%-0.3%-2.6% → -5.0%Stock compensation / revenue1.4%1.8%1.6% → 1.4%Accruals ratio-6.9%-4.3%-0.3% → -6.9%
Earnings & estimates
IDXXSector12 quartersDays to next report1113
Ownership & positioning
IDXXSector12 quartersInsider buys (90d)00Insiders buying (90d)00Insider net value (90d)-$1.17M$0Institutional ownership94.1%99.6%Institutional Δ QoQ+3.2 pp+1.1 ppConviction funds net buying—−0.0 ppActive managers net buying−0.2 pp+0.1 ppActive funds net buying−0.0 pp+0.0 ppDays to cover3.914.29Short % of shares out2.5%6.0%Short interest Δ+0.0 pp+0.1 pp

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Terms of use

Source: SEC EDGAR: Forms 4 (insider trades), 10-Q and 10-K (financials). Insider trades as filed (amendments applied); financial metrics computed by Hand of the Market from the companies' quarterly and annual reports. Each trade links to its filing.

Not investment advice. These signals are starting points for research, not recommendations. Data may contain errors or lag the filings.